Clearmind Medicine (CMND) EBIT Growth (3y) (2025 - 2026)
Powered by 
Analysis
Clearmind Medicine (CMND) EBIT Growth (3y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 7.09% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 12.54% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 51.64% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 19.17% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 7.73% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -15.60% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 53.28% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 1.82% |
| 10 | Clearmind Medicine | 14,742.44 | -13.58 Mn | - | -18.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -18.65% |
| Jan 31, 2026 | -30.16% |
| Oct 31, 2025 | 27.14% |
| Jul 31, 2025 | 6.74% |
| Jan 31, 2025 | 29.85% |